TMO
Thermo Fisher Scientific Inc. · Healthcare · Medical - Diagnostics & Research
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -8.7% ·
Aktienfluss -0.7% ·
neue Nettopositionen -9.5%
— Formel
Breite Distribution — sinkende Anteile und weniger Halter
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 191 | +3 | 260.61M | $131.45B | +5 | −1 |
| Q1 2026 | 190 | +2 | 255.88M | $126.62B | +7 | −6 |
| Q4 2025 | 187 | +3 | 274.75M | $159.19B | +4 | — |
| Q3 2025 | 29 | -1 | 154.46M | $74.90B | +1 | −3 |
| Q2 2025 | 28 | +3 | 123.95M | $50.25B | +3 | — |
| Q1 2025 | 22 | -2 | 60.64M | $30.17B | — | −2 |
| Q4 2024 | 24 | +2 | 61.50M | $31.99B | +2 | — |
| Q3 2024 | 21 | -2 | 44.46M | $27.48B | — | −2 |
| Q2 2024 | 23 | — | 44.78M | $24.75B | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 10.97M | +10.6% | $6.79B | 0.8% | ▲ Add | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 10.97M | +10.6% | $6.79B | 0.8% | ▲ Add | 2 | SEC ↗ |
| 3 | Capital World Investors ✦ | 9.33M | -2.0% | $5.77B | 0.9% | ▼ Trim | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passiv) | 7.66M | +1.7% | $4.72B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passiv) | 7.66M | +1.7% | $4.72B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 6 | Norges Bank ✦ (passiv) | 5.59M | +0.4% | $3.46B | 0.5% | ▲ Add | 2 | SEC ↗ |
| 7 | Fisher Asset Management ✦ | 2.64M | +2.5% | $1.63B | 0.7% | ▲ Add | 2 | SEC ↗ |
| 8 | PRIMECAP Management ✦ | 2.57M | -3.5% | $1.59B | 1.2% | ▼ Trim | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 2.53M | -16.4% | $1.56B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 2.53M | -16.4% | $1.56B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 2.53M | -16.4% | $1.56B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 12 | Wellington Management ✦ | 2.53M | -16.4% | $1.56B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 13 | Wellington Management ✦ | 2.53M | -16.4% | $1.56B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 14 | Wellington Management ✦ | 2.53M | -16.4% | $1.56B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 15 | Wellington Management ✦ | 2.53M | -16.4% | $1.56B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 16 | Wellington Management ✦ | 2.53M | -16.4% | $1.56B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 17 | Marshall Wace ✦ | 627.73K | +89576.1% | $388.30M | 0.5% | ▲ Add | 2 | SEC ↗ |
| 18 | Marshall Wace ✦ | 627.73K | +89576.1% | $388.30M | 0.5% | ▲ Add | 2 | SEC ↗ |
| 19 | Marshall Wace ✦ | 627.73K | +89576.1% | $388.30M | 0.5% | ▲ Add | 2 | SEC ↗ |
| 20 | Baillie Gifford ✦ | 603.39K | -2.9% | $373.24M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 21 | Baillie Gifford ✦ | 603.39K | -2.9% | $373.24M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 22 | Baillie Gifford ✦ | 603.39K | -2.9% | $373.24M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 23 | Baillie Gifford ✦ | 603.39K | -2.9% | $373.24M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 24 | Two Sigma Investments ✦ | 397.23K | -7.2% | $245.71M | 0.6% | ▼ Trim | 2 | SEC ↗ |
| 25 | Adage Capital Partners ✦ | 357.72K | +1.6% | $221.28M | 0.4% | ▲ Add | 2 | SEC ↗ |
| 26 | D. E. Shaw & Co. ✦ | 337.85K | +67.9% | $208.98M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 27 | D. E. Shaw & Co. ✦ | 337.85K | +67.9% | $208.98M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 211.41K | +115.4% | $129.35M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 211.41K | +115.4% | $129.35M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 211.41K | +115.4% | $129.35M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 211.41K | +115.4% | $129.35M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 32 | Arrowstreet Capital ✦ | 206.32K | +588.9% | $127.63M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 33 | Citadel Advisors ✦ | 166.19K | -83.1% | $102.80M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 34 | Citadel Advisors ✦ | 166.19K | -83.1% | $102.80M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 35 | Millennium Management ✦ | 122.48K | -78.3% | $75.76M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 36 | Renaissance Technologies ✦ | 48.95K | -79.2% | $30.28M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 37 | Markel Group ✦ | 35.40K | +20.4% | $21.90M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 38 | Dodge & Cox ✦ | 26.77K | -0.1% | $16.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 39 | Gotham Asset Management ✦ | 23.41K | +10.0% | $14.48M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 40 | GAMCO Investors ✦ | 4.28K | -0.2% | $2.65M | 0.0% | ▼ Trim | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Point72 Asset Management | $186.10M | war 0.6% |
| Bridgewater Associates | $18.65M | war 0.1% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 1 Inhaber, 24.30K Anteile, $11,944 gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Käufe auf dem offenen Markt (P)
Keine Insider-Käufe auf dem offenen Markt in unserem Erfassungszeitraum.
Verkäufe auf dem offenen Markt (S)
Officer, Director · 321 Ant. · $201,941
Officer, Director · 3.01K Ant. · $1.89M
Officer, Director · 1.79K Ant. · $1.12M
Officer, Director · 2.15K Ant. · $1.35M
Officer, Director · 2.73K Ant. · $1.71M
Officer, Director · 560 Ant. · $354,446
Officer, Director · 80 Ant. · $50,719
Officer, Director · 1.31K Ant. · $824,745
Officer, Director · 2.60K Ant. · $1.64M
Officer, Director · 1.25K Ant. · $787,312
Zuteilungen, Ausübungen und Steuereinbehalte werden hier nie als Käufe oder Verkäufe gezählt. Methodik